|
Beta
Peptide Foundation Pty Ltd
Overview
The Beta Peptide Foundation was established in 1997
to develop, manufacture and market skin care products containing
Beta Alistine™ as the main active agent. Beta Alistine™
is an exciting and significant discovery by famous CSIRO scientist
Dr Robin Holliday, who with his team demonstrated for the first
time that Beta Alistine™ restores the youthful appearance
of aged human skin cells in tissue culture.
The discovery of Beta Alistine's many protective and
restorative properties make it an important agent for improving
the quality of skin care. Patents applied for by CSIRO & Peptech
Ltd protect these discoveries, which have been licensed to the Beta
Peptide Foundation Pty Ltd.
In another significant Australian breakthrough, Scientists have
demonstrated that a natural milk protein complex stimulates the
production of human skin collagen as well as improving overall skin
function. In laboratory tests, topical application of the protein
complex - MPF-1 - boosted collagen in aged human skin cells by 500%.
The remarkable properties of MPF-1 were discovered
by researchers from the Co-Operative Research Centre for Tissue
Growth and Repair in Adelaide, Australia, and patented by TGR BioSciences
Pty Ltd. Beta Peptide Foundation Pty Ltd holds the exclusive licensing
rights worldwide.
Marketing, product development and sales are managed
from the Beta Alistine™ Skin Science head office in Sydney,
Australia.
Competitive
Advantages
1. The marriage between science, design and innovation
The incorporation of all of the above factors into
a finished product that is both effective and desirable has been
key.
We have developed a range of skin care that are of a world-class
quality while being simple to use. The products communicate easily
to the consumer and sales across all 12 products are consistent
and healthy.
2. Our commitment to PR and it’s value in the
communication process
Operating originally from a small budget has presented
challenges in the way we communicate the brand.
Therefore, we embraced an approach of blanket PR coverage involving
women’s magazines and beauty pages, science writers to communicate
innovations, current affair programs on prime time television and
radio interviews with key Scientists.
All of these activities and their frequency have been successful
in keeping us front of the consumers mind and enabled us to grow
our retail business in Australia and the UK substantially.
We are strongly aided in this as we are Australian owned and made
and support from the media for our affiliations has been significant.
3. Strong relationships with retail partners and distributors.
Due to the success of Beta Alistine Skin Science on
both the Australian and UK Markets we are committed to the future
and the export potential of our products.
Our collaborations with Australian Science and Innovation
allow us a point of difference that is highly prized commercially.
We are able to use leading edge technology to create products at
the cutting edge of their market segment. Our small organisation
means that we are able to act quickly making decisions that directly
impact our business, within a minimum time frame.
We create partnerships with distributors in each market
and then guide them with international marketing strategies that
both maintain brand image and philosophy, while speaking directly
to the consumer.
Our future success lies in critical mass and at the
company’s full potential we envisage that the brand will be
exported to the following markets and negotiations are underway
to realise this.
In short, at full potential the Beta Alistine brand
name would be recognised as a market leader in the production, marketing
and export of scientifically based skin care preparations derived
from good Australian Science and Innovation.
Technology
Science behind the Company.
How can science help to slow down skin aging and repair
age-damaged skin.
Recent discoveries of novel natural products whose
main function is to slow down processes of aging and to repair damage,
which has occurred, are the scientific basis of the Beta Alistine™
products.
The novel active agents in the company's products
are all naturally occurring peptides (peptides are strings of amino
acid subunits). They are Beta Alistine™, and milk whey protein
fraction MPF-1.
Beta Alistine™ is a most remarkable substance.
It is found in large amounts in all mammals (and in many other animals)
but only in the longest living cells and tissues viz., muscle, brain
neurons and eye lens tissue. In young persons about 5% of the dry
weight of muscle and of eye lens are Beta Alistine™, but it
is present only in minute amounts in skin tissue.
A few years ago the world famous scientist Dr. Robin
Holiday FRS, discovered a way to extend the life of human skin cells
with the aid of Beta Alistine™. Subsequently the discovery
was patented with Dr. Holliday, Gail MacFarland and Dr. Geoffrey
Grigg named as inventors.
Beta Alistine™ has a number of other important
properties.
It protects skin against UV-induced cross-linking
of collagen.
It protects tissues and cells against non-enzymic
glycation and the formation of AGE compounds in cells and in tissues.
AGE's are associated with, and increase the rate of
aging in tissues.
It protects against damaging lipid peroxidation.
It blocks the Fenton reaction (the Fenton reaction
causes the generation and release of the very reactive and damaging
oxygen species hydroxy free radicals).
It metabolises any hydroxy free radicals which are
present in cells and tissue.
As a consequence of its several protective chemical
activities Beta Alistine™ speeds up the repair of many types
of skin blemishes and conditions including some types of contact
dermatitis, acne, discoloration of the skin and skin roughness.
Whilst the remarkable properties of Beta Alistine™
and its presence in certain tissues of the human body, seem centred
on protecting the latter against damage to these tissues and maintaining
them in a youthful and functional form for as long as possible,
the properties of the second active peptide agent, MPF-1 caste it
as repairer of damage and restorer of function.
MPF-1 is a concentrated protein extract from milk.
The properties of MPF-1 were discovered by a group
of Adelaide scientists working on a major government funded project.
By carefully extracting lower molecular weight proteins from milk
whey, they isolated a fraction which was enriched in a number of
important and active tissue growth factors in their native form.
The mixture of these growth factors had potent wound
healing properties but more importantly for skin science, the mixture
was able to stimulate the synthesis of components of cells which
are depleted in aged cells, to help restore functions and structure
characteristics of juvenile skin.
MPF-1 contains relatively substantial amounts of the
growth factor EGF(Epidermal Growth Factor), PDGF(Platelet-Derived
Growth Factor), IGF-2(Insulin-like Growth Factor 2), TGFbeta-1 and
TGFbeta-2 and Betacellulin.
TGFbeta-1 and TGFbeta-2 are master growth factors,
which play a major role in organising the repair of tissue damage,
and also have potent anticancer functions.
EGF, IGF, IGF-2 and Betacellulin stimulate the division
of cells of the skin epidermis and dermis to help restore the normal
cell density of juvenile skin tissue.
MPF-1 not only enhances skin cellularity, it also
stimulates the productions of new collagen in old skin cells.
The skin of a 70-year-old person has only half of
that of a 17-year-old.
Moreover, the collagen, which is present in aged skin,
is substantially damaged. Since collagen in juvenile skin comprises
80% of the dry weight of the skin and is responsible for much of
the youthful skin's physical structure, appearance, feel, function
and its ability to store water in the skin tissues, its loss has
serious consequences to skin texture, feel and function.
In laboratory trials at the CRC (Cooperate Research
Centre) for Tissue Growth and Repair in Adelaide, Australia, MPF-1
increased collagen synthesis in old cells by 500%.
This figure can be compared to the few percentage increase observed
with a number of other agents being marketed by several large cosmetic
companies.
In addition MPF-1 strongly inhibits the collagen-damaging
effects of the skin's metalloproteinases responsible for much of
the damage to the skin structure following exposure to strong sunlight.
The production of these damaging enzymes is stimulated
by exposure of the skin to strong sunlight.
MPF-1 was found also to repair small skin wounds and
lesions very effectively.
Beta Peptide Foundation found that its Rocket Science
line delete time suspension plus+product, containing MPF-1, was
particularly useful for restoring skin structure and appearance.
For best results it should be massaged into the skin followed immediately
afterwards by the application of Beta Alistine™ skin science
age delete moisturising face cream.
Corporate
Alliances/Partnerships
Partnering Opportunities
Distributors
| Contact Person |
Linda Ulstein |
 |
| Job Title |
Executive Director |
| Address |
191 Darling Street |
| City/Suburb |
Balmain
NSW 2041 Australia |
| Email |
linda@betaalistine.com.au |
| Phone |
+61 2 9818 7009 |
| Fax |
+61 2 9818 8566 |
| Website Address |
www.betaalistine.com.au |
back
|
